መነሻ › የሳንባ ካንሰር › ኮነቲከት › New London
በNew London፣ CT ለየሳንባ ካንሰር የሚደረጉ ክሊኒካዊ ጥናቶች
ለየሳንባ ካንሰር የሚደረጉ 5 ጥናቶች በNew London እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።
Official study text (English)
ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Smilow Cancer Hospital Care Center - Waterford, Waterford · 2 ማይል ርቀት
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Smilow Cancer Hospital Care Center - Waterford, Waterford · 2 ማይል ርቀት
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Smilow Cancer Hospital Care Center - Waterford, Waterford · 2 ማይል ርቀት
- Smilow Cancer Hospital Care Center - Westerly, Westerly · 14 ማይል ርቀት
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
ተሳታዮችን በመፈለግ ላይደረጃ 2/3
- Smilow Cancer Hospital Care Center - Waterford, Waterford · 2 ማይል ርቀት
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Smilow Cancer Hospital Care Center - Waterford, Waterford · 2 ማይል ርቀት
በሌሎች ከተሞች ለየሳንባ ካንሰር የሚደረጉ ጥናቶች
- Houston, TX78 ጥናቶች
- Boston, MA62 ጥናቶች
- New York City, NY60 ጥናቶች
- Los Angeles, CA45 ጥናቶች
- Arlington, VA41 ጥናቶች
- Washington, DC41 ጥናቶች
- Chicago, IL41 ጥናቶች
- Baltimore, MD40 ጥናቶች
- Nashville, TN40 ጥናቶች
- St. Louis, MO39 ጥናቶች
- Columbus, OH37 ጥናቶች
- Philadelphia, PA36 ጥናቶች
በNew London ውስጥ ያሉ ሌሎች ጥናቶች
ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ6 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።